Table 1 Baseline Characteristics
Variable, n (%) | Sub study Patients (N = 100) | Non Sub study Patients (N = 713) | P value |
|---|---|---|---|
Age [years] | 67.1 (57.6, 71.3) | 66.4 (59.5, 72.0) | 0.71 |
Male gender | 66 (66.0) | 531 (74.5) | 0.09 |
Ischemic History | 47 (47.0) | 292 (41.0) | 0.28 |
Diabetes | 24 (24.0) | 183 (25.7) | 0.81 |
Duration of HF, [months] | 4.3 (1.5, 8.1) | 4.0 (1.5, 7.9) | 0.80 |
ACE/ARB | 97 (97.0) | 673 (94.4) | 0.35 |
Betablockers | 83 (83.0) | 503 (70.6) | 0.009 |
Loop Diuretics ≥ 80 mg furosemide or equivalent | 63 (63.0) | 289 (40.5) | <.0001 |
Aldosterone antagonists | 73 (73.0) | 384 (53.9) | 0.0003 |
Digoxin | 53 (53.0) | 293 (41.1) | 0.03 |
Aspirin | 68 (68.0) | 292 (41.0) | <.0001 |
Warfarin | 28 (28.0) | 249 (34.9) | 0.18 |
Statins | 37 (37.0) | 284 (39.8) | 0.66 |